Conclusions-Transplant-free survival is poor for restrictive cardiomyopathy in childhood. Survival is independent of phenotype; however, the restrictive cardiomyopathy/hypertrophic cardiomyopathy phenotype has significantly better transplant-free survival. 
Summary-The atherogenic process has important determinants early in life. Childhood exposure to ozone may be a novel risk factor for carotid artery intima-media thickness in young adults. Exposure to ambient air pollutants increases risk for cardiovascular health outcomes in adults. Early life exposure to ozone has been associated with childhood lung function development. Systemic inflammation induced first in the lung may be propagated throughout the body to target other organ systems. Regulation of air pollutants and efforts that focus on limiting childhood exposures continue to be important public health goals to potentially reduce atherosclerotic burden and its consequences.
Conclusions-Childhood exposure to O3 may be a novel risk factor for carotid artery intima-media thickness in a healthy population of college students. Regulation of air pollutants and efforts that focus on limiting childhood exposures continue to be important public health goals. 1 
Parental Electrocardiographic Screening Identifies a High Degree of Inheritance for Congenital and Childhood Nonimmune Isolated Atrioventricular Block
Summary-The origin of congenital or childhood nonimmune isolated atrioventricular (AV) block remains unknown. Because familial clustering of progressive cardiac conduction defects of unknown causes, including congenital AV block, has been reported, we hypothesized that idiopathic AV block in the young may be a heritable disease. This hypothesis was tested in a nationwide (France) retrospective cohort of 141 idiopathic pediatric AV blocks. Screening ECGs from 130 parents (mean age 42.0±6.8 years, 57 couples) were compared with 130 matched healthy control subjects. Although a family history of sudden death or progressive cardiac conduction defect, respectively, was found in only 1.4% and 11.1% of parents, conduction abnormalities were more frequent in parents than in control subjects, found in 50.8% versus 4.6%, respectively (P<0.001), and estimated heritability for isolated conduction disturbances was 91% (standard error, 1.019; P=2. 10−16) . SCN5A mutation screening identified 2 mutations in 2 patients among 97 children. Thus, ECG screening in parents of children affected by idiopathic AV block revealed diffuse subclinical impairment of cardiac conduction, which provides strong evidence for a genetic origin in congenital and childhood nonimmune isolated AV block. Such an ECG screening may be helpful in clinical practice if other obvious causes have been ruled out. Heritability estimate confirmed a high contribution of genetic factors, which opens the field to further molecular studies.
Conclusions-ECG screening in parents of children affected by idiopathic AV block revealed a high prevalence of conduction abnormalities. These results support the hypothesis of an inheritable trait in congenital and childhood nonimmune isolated AV block. 2 
Outcomes of Restrictive Cardiomyopathy in Childhood and the Influence of Phenotype: A Report From the Pediatric Cardiomyopathy Registry
Summary-Restrictive cardiomyopathy is a rare form of cardiomyopathy in childhood with a few risk factors identified for death or transplantation. This analysis from the Pediatric Cardiomyopathy Registry identified 152 cases of restrictive cardiomyopathy among 3375 children with cardiomyopathy (4.5%), approximately one-third of whom had a mixed restrictive/hypertrophic phenotype. Survival did not differ between those with pure and mixed phenotypes, but transplant-free survival was inferior in the pure restrictive cardiomyopathy group. Overall outcomes were worse than for all other forms of cardiomyopathy in the Pediatric Cardiomyopathy Registry. Clinical and echocardiographic risk factors at presentation for worse outcome were identified and should aid the clinician in risk stratification.
Among the factors studied were age, duration of illness, sex, race, ventricular geometry, and the clinical or histological diagnosis of myocarditis at presentation. We found that death while waiting was associated with ventilator use and older age at listing. A shorter duration of illness was associated with a more urgent listing status (United Network for Organ Sharing status 1). Death after transplantation was associated black race and lower left ventricular end-diastolic dimension z score at presentation. We also found that death after transplantation was associated with the diagnosis of myocarditis at presentation (P<0.009). Death while waiting was not associated with the diagnosis of myocarditis, and 97% of children with myocarditis survived to transplantation. Furthermore, the most common cause of death after transplantation in the myocarditis group was acute rejection (17%). This is the first study to show that children with dilated cardiomyopathy and myocarditis have significantly higher posttransplantation mortality compared with children without myocarditis. This finding suggests that preexisting viral infection or inflammation could adversely affect heart allograft survival and has implications for the management of these children before and after heart transplantation in the future.
Conclusions-Mechanical ventilator use and older age at listing predicted death while waiting, whereas nonwhite race, smaller left ventricular dimension, and myocarditis were associated with death after transplantation. Although 97% of children with clinically or biopsydiagnosed myocarditis at presentation survived to transplantation, they had significantly higher posttransplantation mortality compared with children without myocarditis, raising the possibility that preexisting viral infection or inflammation adversely affects graft survival. 4 
Relationship Between Arterial Partial Oxygen Pressure After Resuscitation From Cardiac Arrest and Mortality in Children
Summary-Postresuscitation care is an important component that affects outcome after cardiac arrest. Adult studies have suggested a relationship between exposure to hyperoxia and survival in this setting. We undertook a national retrospective cohort study that involved 1875 patients from all pediatric intensive care units in the United Kingdom and Ireland to investigate the relationship between arterial partial oxygen pressure (PaO 2 ) after resuscitation from cardiac arrest and mortality. We found exposure to supranormal oxygen tension was common, with 33% of patients having PaO 2 >150 mm Hg on the first blood gas. We demonstrated a significant association between early postarrest hyperoxia and increased mortality after admission to the pediatric intensive care unit. A stronger association was also seen between the degree of hypoxia and mortality. Our data lend support for intervention studies to assess the safety and efficacy of using the lowest inspired oxygen concentration that maintains arterial oxyhemoglobin saturation of 94% to 96% in the postresuscitation period.
Conclusions-Both severe hypoxia and, to a lesser extent, hyperoxia are associated with an increased risk of death after pediatric intensive care unit admission after cardiac arrest. 
Manifestations of Neonatal Lupus
Summary-A recent case-control study suggested a benefit of hydroxychloroquine (HCQ) in lowering the risk of cardiac manifestations of neonatal lupus (cardiac-NL) in pregnancies of anti-SSA/Ro-positive patients with systemic lupus erythematosus. In this study, we examined whether HCQ reduces the ≈10-fold higher recurrence rate in cardiac-NL by identifying 257 pregnancies of anti-SSA/Ro-positive mothers (40 exposed and 217 unexposed to HCQ) after the birthof a child with cardiac-NL from 3 international databases. Exposure was defined as the sustained use of HCQ throughout pregnancy with initiation before 10 weeks of gestation. The recurrence rate of cardiac-NL in fetuses exposed to HCQ was 7.5% (3 of 40) compared with 21.2% (46 of 217) in the unexposed group (P=0.050). There were no deaths in the HCQ-exposed group, whereas the overall case fatality rate of the cardiac-NL fetuses in the unexposed group was 21.7%. In a multivariable analysis, HCQ use remained significantly associated with a decreased risk of cardiac-NL (odds ratio, 0.23; P=0.037). Similar results (odds ratio, 0.18; P=0.011) were obtained with propensity score analysis, an alternative approach to adjust for possible confounding by indication. Data obtained from this multinational historical cohort study suggest that HCQ use in a mother with anti-SSA/Ro antibodies and a previous child with cardiac-NL may reduce the riskof cardiac-NL recurrence in a subsequent offspring. Further prospective studies are needed to confirm these findings.
Conclusions-Aggregate data from a multinational effort show that in mothers at high risk of having a child with cardiac-NL, the use of HCQ may protect against recurrence of disease in a subsequent pregnancy.
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Costs and Benefits of Targeted Screening for Causes of Sudden Cardiac Death in Children and Adolescents
Summary-This article examines the cost-effectiveness of ECG screening in 2 asymptomatic pediatric populations for whom it has been recommended: school-aged children with attention-deficit/hyperactivity disorder for whom stimulants are being considered and adolescents participating in sports. The risk of sudden cardiac death in these pediatric patients is very low, even compared with groups of young adults themselves only several years out of their own childhood. However, several cardiac disorders are capable of presenting as sudden cardiac death in the pediatric community. If these disorders were diagnosed while the patient is asymptomatic, it is assumed that appropriate treatments and avoidance of stimulant medication and/or stressful athletic activity may mitigate that risk. Only a handful of the several disorders that have been linked to pediatric SCD are (1) typically asymptomatic in the school-aged child and adolescent, (2) identifiable on ECG, and (3) sufficiently prevalent to warrant targeted screening compared with rarer disorders. We developed decision analyses models for ECG screening for 3 disorders that meet these criteria and hence are considered potentially appropriate targets for ECG screening programs: hypertrophic cardiomyopathy, Wolff-Parkinson-White syndrome, and long-QT syndrome. However, our findings indicate that, even under the conditions that might be expected to favor screening used in our base case, estimates of the cost-effectiveness of screening for these diseases are relatively unfavorable, ranging from $91 000 (adolescent participating in sports) to $204 000 per life-year (child with attention-deficit/hyperactivity disorder).
Conclusions-Results based on assumptions favoring sudden cardiac death screening indicated that its cost is high relative to its health benefits. Summary-Hypoplastic left heart syndrome is a common form of functional single-ventricle congenital heart disease and is associated with significant morbidity/mortality. A National Heart, Lung, and Blood Institute Pediatric Heart Network study, the Single Ventricle Reconstruction trial, randomized initial surgical Norwood palliation in 549 infants with hypoplastic left heart syndrome to either a right ventricle-pulmonary artery shunt or a modified Blalock-Taussig shunt to determine the optimal surgical approach. The primary result of the trial found better 1-year transplant-free survival in subjects who received a right ventricle-pulmonary artery shunt compared with those who had a modified Blalock-Taussig shunt. This study compared 2-dimensional echocardiographic indices to assess the effect of initial shunt type at 4 stages during the trial (at baseline preoperatively, early after the Norwood procedure, immediately before the second-stage surgical procedure, and at 14 months of age). We found that differences in neoaortic annular size and flow patterns between shunt types when the shunts are in place can likely be explained by the different physiologies created rather than by intrinsic differences in cardiac function. After the shunt was removed at the second-stage surgery, echocardiographic indices were similar between the 2 groups, including measures of right ventricular function, cardiac and vascular dimensions, neoaortic and tricuspid dimensions and valve function, and neoaortic flow patterns. This lack of shunt-related differences in echocardiographic indices of cardiac and vascular function in survivors of the Norwood procedure at 14 months suggests that the best initial surgical pathway for infants with hypoplastic left heart syndrome remains unclear and emphasizes the importance of longitudinal follow-up of this unique cohort.
Conclusions-Indices of cardiac size and function after the Norwood procedure are similar for modified Blalock-Taussig shunt and right ventricle-pulmonary artery shunt by 14 months of age. Interstage differences between shunt types can likely be explained by the physiology created when the shunts are in place rather than by intrinsic differences in cardiac function. Summary-Kawasaki disease (KD) is now recognized as the leading cause of acquired heart disease in children in the United States and developed world. The underlying cause of KD and the mechanisms leading to vessel inflammation, coronary artery lesions, and aneurysms, which are the hallmarks of KD, remain largely unknown. Standard therapy with intravenous immunoglobulin (IVIG) effectively reduces the incidence of coronary arterial lesions, but 10% to 20% of patients with KD fail to respond to IVIG and thus show a high prevalence of coronary lesions. There is no definitive treatment recommendation for patients who fail to respond to an initial course of IVIG treatment. Rescue treatment for IVIG resistance includes additional IVIG dose(s), steroids, anti-tumor necrosis factor monoclonal antibody, and cyclosporine A, but these approaches have shown mixed results, and the effectiveness of these therapies remains controversial. Development of an optimal alternative for IVIG-resistant KD patients is now an urgent matter. Using a wellestablished KD mouse model, we found that interleukin-1β is critically involved in the development of coronary arteritis and myocarditis in KD mice and that these lesions can be prevented by treatment with an interleukin-1 receptor antagonist. These observations provide mechanistic insights into the cellular and molecular understanding of the vasculitis and coronary arteritis in the KD mouse model and suggest that anti-interleukin-1β agents might prevent the development of coronary lesions in KD patients. Our findings provide justification for future prospective multicenter clinical trials to determine the efficacy of therapies designed to block interleukin-1β-dependent signaling in children with KD.
Conclusions-Our results strongly suggest that caspase-1 and IL-1β play critical roles in the development of coronary lesions in this KD mouse model, blocked by IL-1 receptor antagonist. Therefore, anti-IL-1β treatment strategies may constitute an effective, more targeted treatment of KD to prevent coronary lesions. Summary-The prevalence of metabolic syndrome in adolescence has gradually increased to approximately 10% in the United States and Western Europe. Because it is strongly associated with adult metabolic syndrome, subclinical atherosclerosis, and type 2 diabetes mellitus, the early detection of children at high risk may have potential clinical impact. After assessment of an overall urban population of 2361 white children and adolescents over a 10-year period, the present study showed that birth measurements and family history can be helpful for the practicing clinician in classifying children according to risk of metabolic syndrome in adolescence. The coexistence of low birth weight (<10th percentile) and small birth head circumference (<10th percentile) together with parental (in at least 1 parent) overweight or obesity was found to predict metabolic syndrome in adolescence with a sensitivity of 91% and a specificity of 98%. Thus, the coexistence of low birth weight, small head circumference, and parental history of overweight or obesity may be helpful in targeting children at risk for developing metabolic syndrome in adolescence who may benefit especially from early institution of heart-healthy behaviors.
Conclusions-The coexistence of low birth weight, small head circumference, and parental history of overweight or obesity may be useful for detection of children at risk of developing metabolic syndrome in adolescence.
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Prevalence of Cardiomyopathy in Italian Asymptomatic Children With Electrocardiographic T-Wave Inversion at Preparticipation Screening
Summary-T-wave inversion (≥2 contiguous leads) on a 12-lead ECG is usually dismissed in children as a normal "juvenile pattern of repolarization." However, T-wave inversion is a common ECG abnormality of inherited heart muscle diseases such as hypertrophic cardiomyopathy and arrhythmogenic right ventricular cardiomyopathy, which are leading causes of sudden cardiac death in young competitive athletes. These cardiomyopathies are genetically determined and show an age-dependent phenotypic expression. Because early disease manifestations usually occur after puberty, the persistence of T-wave inversion in the postpubertal age raises the problem of differential diagnosis between a developing heart muscle disease and a benign juvenile pattern of repolarization. The present study was designed to assess prospectively the prevalence, age relation, and underlying cardiomyopathy of T-wave inversion in a large, consecutive series of Italian children (2765) with a mean age of 13.9±2.2 years (range, 8-18 years) undergoing preparticipation screening. In this age group, T-wave inversion, localized predominantly in the right precordial leads, was documented in 5.7% of cases, significantly decreased with increasing age and pubertal development, and most important, reflected an underlying cardiomyopathy such as arrhythmogenic right ventricular cardiomyopathy and hypertrophic cardiomyopathy in 2.5% of cases. These results indicate that after complete August 20, 2013 pubertal development, T-wave inversion becomes significantly less common than traditionally believed, and its persistence may suggest an underlying heart muscle disease at risk of sudden cardiac death. As a corollary, demonstration of postpubertal persistence of T-wave inversion in children engaged in competitive sports activity justifies an echocardiographic investigation, which may lead to presymptomatic identification of early cardiomyopathy.
Conclusions-The prevalence of T-wave inversion decreases significantly after puberty. Echocardiographic investigation of children with postpubertal persistence of T-wave inversion at preparticipation screening is warranted because it may lead to presymptomatic diagnosis of a cardiomyopathy that could lead to sudden cardiac death during sports.
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A Randomized, Double-Blind, PlaceboControlled, Dose-Ranging Study of Oral Sildenafil Citrate in Treatment-Naive Children With Pulmonary Arterial Hypertension Summary-Pulmonary arterial hypertension is an important cause of morbidity and mortality in children and adults. Currently, 8 drugs are approved for adult pulmonary arterial hypertension, yet no drugs are approved for children. Because of similar clinical characteristics and histopathology, treatment for children has been extrapolated from evidence-based adult guidelines. However, better information is required to provide optimal pediatric dosing and to ensure safety in children of all ages. The 16-week, randomized, double-blind, placebocontrolled Sildenafil in Treatment-Naive Children, Aged 1 to 17 Years, With Pulmonary Arterial Hypertension (STARTS-1) study evaluated the effects of sildenafil in childhood pulmonary arterial hypertension. Treatment-naive children with pulmonary arterial hypertension (n=234; aged 1-17 years; ≥8 kg) received low-, medium-, or highdose sildenafil or placebo orally 3 times daily. Peak oxygen consumption, measured only in children who were able to reliably perform exercise testing (using cycle ergometry), was the primary end point. Hemodynamic parameters and World Health Organization functional class were assessed across all patients, including those unable to reliably perform exercise testing. Although the primary comparison of percent change in peak oxygen consumption for the 3 sildenafil groups combined was only marginally statistically significant, the improvements in exercise capacity, functional class, and hemodynamics with medium-and high-dose sildenafil suggest efficacy with these doses. Combined with interim data from the ongoing extension study, the overall profile favors the medium dose. Further investigation is warranted to determine optimal dosing based on age and body weight.
Conclusions-Sixteen-week sildenafil monotherapy is well tolerated in pediatric pulmonary arterial hypertension. Percent change in PVȮ2 for the 3 sildenafil doses combined was only marginally significant; however, PVȮ2, functional class, and hemodynamic improvements with medium and high doses suggest efficacy with these doses. Combined with STARTS-2 data, the overall profile favors the medium dose. Further investigation is warranted to determine optimal dosing based on age and weight. pediatric cohort is the most comprehensive prospective database of group 1 childhood pulmonary arterial hypertension reported to date. The size of the study (n=216), number of referral sites (n=26), and geographical distribution make the observations generalizable to clinical US practice. Although descriptive, the information is potentially useful for clinicians because it is a mixed incidence and prevalence cohort collected over 3 years. We describe the characteristics and outcomes of the cohort, and we identify key predictors of survival in childhood pulmonary arterial hypertension.
Conclusions-Using REVEAL, we identified key predictors of survival in childhood pulmonary arterial hypertension. Refining these prognostic parameters should help clinicians improve outcomes. 13 
Impact of Cardiac Devices on the Quality of Life in Pediatric Patients
Summary-To date, there has been a paucity of data with regard to quality of life (QOL) in pediatric patients with implanted defibrillators and pacemakers. In this study, QOL was assessed using both general pediatric and cardiac-specific QOL measurement tools. It was demonstrated that defibrillators, as well as pacemakers, have significant effect on patient QOL, which is further modified by device type as well as other patient characteristics, such as congenital heart disease. Furthermore, specific psychological factors that correlate with improved or worsened QOL, as well as key differences in drivers of QOL between patients and their parents, were identified. These data should both raise awareness of this effect on QOL and help design patient-specific psychological management strategies to mitigate these deleterious effects.
Conclusions-Patient QOL is significantly affected by the presence of cardiac rhythm devices. Whether these effects can be mitigated through the use of psychotherapy needs to be assessed. 14 
Demographics, Trends, and Outcomes in Pediatric Acute Myocarditis in the United States, 2006 to 2011
Summary-Pediatric acute myocarditis has a heterogeneous clinical presentation, and its accurate diagnosis is difficult. There is lack of sufficient evidence-based diagnostic and treatment guidelines for management of pediatric acute myocarditis. There is significant regional variability and temporal changes in treatments used for pediatric myocarditis during the past 5 years in the United States. Myocarditis continues to have significant morbidity and mortality, with a large percentage of patients requiring mechanical cardiovascular support.
Conclusions-There is significant temporal and regional variation in the diagnostic modalities and management used for pediatric myocarditis, which continues to have high morbidity and mortality. Extracorporeal membrane oxygenation, ventricular assist device, and vasoactive medications are independently associated with increased mortality/transplantation. 
The Editors Most Read Articles on the Topic of Pediatric Cardiology e111
Allometric scaling allows for accurate correction of chamber size for changes in body size (body surface area [BSA]), age, and sex. We have used this science to derive validated allometric models for the left atrial volume (LAV). In our study, we derived and validated an allometric model for children with BSA ≤1 m2 and >1 m2. The allometric models were further validated in a prospective cohort of children with structurally normal hearts and BSA. Indexing chamber volumes using BSA to the exponent of 1 is physiologically incorrect, and this has been published previously for left ventricular volumes. Results of our analysis show that z scores for indexed LAV should be based on indexing LAV/BSA1.48 and LAV/BSA1.08 in children with BSA ≤1 m2 and >1 m2, respectively. Using the validated allometric model will allow for accurate diagnosis of left atrial enlargement that will be independent of patients' body size, age, and sex. The z-score graphs provided will allow for referencing and allocation of z scores for measured LAV.
Conclusions-This study demonstrates the fallacy of using "per-BSA1 standards" for normalization of LAV in pediatrics. LAV/ BSA1.48 for children with BSA≤1 m2 and LAV/BSA1.08 for those with BSA>1 m2 is accurate and can be used to derive Z-scores.
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Conduction Abnormalities in Pediatric Patients With Restrictive Cardiomyopathy
Summary-The findings of this review of pediatric patients with restrictive cardiomyopathy reiterate the high-risk nature of this unique patient population secondary to its association with potential sudden cardiac death. Although tachyarrhythmias will continue to be a major concern in this disease process, the risk of associated lifethreatening bradyarrhythmias should not be overlooked. Secondary to the proposed link to central conduction system disease, most notably progressive AV nodal disease, seen in this study, close surveillance with ECG and ambulatory monitoring is warranted. In this study, PR prolongation and a wider QRS complex were associated with an acute cardiac event. The effectiveness of prophylactic pacing in this population as a bridge to cardiac transplantation or potentially as a means to delay listing for cardiac transplantation in patients with preserved pulmonary vascular resistance must be evaluated.
Conclusions-Pediatric patients with restrictive cardiomyopathy are at risk for acute high-grade heart block, and, in this cohort, bradycardic events represented a significant portion of all arrhythmic events. Aggressive ECG monitoring strategies looking for conduction system disease should be ongoing in all patients with restrictive cardiomyopathy. Implantation of a defibrillator/pacemaker should be considered as prophylactic management.
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Outcomes of Children Following a First Hospitalization for Dilated Cardiomyopathy
Summary-Dilated cardiomyopathy (DCM) in children is a heterogeneous disease with a variable clinical course. Whereas some patients with DCM can remain relatively clinically stable for several years, others show a more precipitous decline, leading to death or requiring heart transplantation within 1 to 2 years following diagnosis. We hypothesized that the first hospitalization for DCM represents an inflection point in a patient's disease trajectory for which death or the need for cardiac transplantation within 1 year was likely. Furthermore, we hypothesized that certain clinical, laboratory, and echocardiographic findings present at the time of first hospital admission were predictive of hospital and 1-year outcomes. The results of this study demonstrate that the first hospitalization for DCM marks a period of high risk for clinical decline, end stage heart failure, and the need for cardiac transplantation when compared with studies of pediatric patients with DCM using time of diagnosis as the study entry point, and that fractional shortening, left ventricular ejection fraction, uric acid, mixed venous saturation, and atrial filling pressures may aid in predicting outcomes. The results of this study may aid practitioners to identify at-risk patients who may benefit from closer outpatient observation, and, perhaps, earlier consideration for cardiac transplantation.
Conclusions-The first hospitalization for dilated cardiomyopathy marks a period of high risk for clinical decline, end stage heart failure, and the need for cardiac transplantation. Echocardiographic function and hemodynamic and serum measurements may aid in predicting outcomes. Despite medical management, most patients will be rehospitalized and/or require cardiac transplantation within 1 year of admission.
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Current Outcomes in US Children With Cardiomyopathy Listed for Heart Transplantation
Summary-Previous studies have reported worse outcomes in children with nondilated cardiomyopathy (CMP) listed for a heart transplant compared with children with dilated CMP. Because wait-list and posttransplant outcomes in children listed for a heart transplant have improved in recent years, the authors sought to compare these outcomes between children with dilated and nondilated forms of CMP in the current era. They analyzed all children <18 years of age with CMP listed for heart transplant in the United States between July 2004 and December 2010. Of 1436 children analyzed, 83% had dilated and 17% had nondilated form of CMP (167 with restrictive CMP, 72 with hypertrophic CMP). In adjusted analysis, children with nondilated CMP were at higher risk of dying on the wait-list (or becoming too sick to transplant) only if they were on a ventilator support at the time of listing. The risk was similar between the groups among children not on a ventilator support. In children who received a transplant, posttransplant 1-year survival was 94% in children with dilated CMP and 89% in children with nondilated CMP. In adjusted analysis, the risk of posttransplant graft loss was 1.8× in children with nondilated versus those with dilated cardiomyopathy. The authors conclude that the increased risk of dying on the wait-list among children with nondilated CMP is limited to those on a ventilator support at listing. The risk of posttransplant graft loss remains modestly higher in children with nondilated CMP. However, their short-term transplant outcomes are good.
Conclusions-The increased risk of wait-list mortality in children with nondilated CMP is limited to those on ventilator support at listing. Although the risk of graft loss is modestly higher in children with nondilated forms of CMP, their short-term transplant outcomes are good.
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Cardiac Allograft Function During the First Year after Transplantation in RejectionFree Children and Young Adults
Summary-Heart transplantation (HT) is an established therapy in children with end-stage heart failure. Although severe early graft dysfunction after HT is rare, mild ventricular dysfunction is common even without rejection and may persist for years. Pulsed-wave tissue Doppler imaging (PW-TDI) is geometry-independent and allows quantification of both left ventricular and right ventricular (RV) function during systole and diastole. In this study, we analyzed serially performed PW-TDI studies in 44 pediatric HT recipients (median age at transplant 7.3 years) who remained rejection-free during the first year post-transplant to investigate the natural history of recovery of ventricular function. We used data from PW-TDI studies in 380 healthy children to transform patient data into age-adjusted z scores to allow better interpretation of raw PW-TDI data in the study children. We found biventricular systolic and diastolic dysfunction early after HT with most significant impairment in RV systolic function and RV and left ventricular early-diastolic filling. Although other aspects of left ventricular and RV function normalized in 6 to 9 months, RV systolic function remained abnormal 1-year post-transplant. Serial cardiac catheterization studies showed that RV and left ventricular filling pressures were elevated early after HT and declined gradually during the first year. These findings provide important insights into the natural history of recovery of biventricular function in pediatric HT recipients and improve our understanding of RV dysfunction in these patients. We suggest that a better understanding of ventricular function in rejection-free patients may also help in developing a PW-TDIbased rejection-surveillance protocol in pediatric HT recipients.
Conclusions-Pediatric HT recipients have biventricular dysfunction using pulsed-wave tissue Doppler imaging early after HT with most significant impairment in RV systolic function and RV and LV early-diastolic filling. Although other aspects of LV and RV function normalize in 6 to 9 months, RV systolic function remains abnormal 1 year-post-transplant.
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Magnetic Versus Manual Catheter Navigation for Ablation of Free Wall Accessory Pathways in Children
Summary-Catheter ablation for supraventricular tachycardia is now a well-established treatment modality in children. Recent advances in electroanatomic mapping and catheter navigation have enhanced our capability to map and ablate arrhythmias in this population. Little data exist regarding the use of magnetic navigation for ablation of accessory pathway-mediated tachycardia in children. We report a single-center cohort study with retrospective review of prospectively collected data on all patients who underwent radiofrequency ablation of accessory pathways at our institution since magnetic navigation was introduced. The efficacy and safety between a magnetically guided approach and standard manual techniques for mapping and ablation were compared. Acute success rates were equivalent between the 2 groups, and recurrence rates were also similar. There was no difference in total procedure time, but mean fluoroscopy time was significantly reduced in the magnetic navigation group at 14 minutes compared with 28 minutes in the manual ablation group. There were no complications observed in either group. This is the first study demonstrating that magnetic navigation appears to be a safe and effective approach to ablate accessory pathway-mediated tachycardia in children.
Conclusions-Magnetic navigation is a safe and effective approach to ablate AP-mediated tachycardia in children.
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Prevalence of Sequence Variants in the RAS-Mitogen Activated Protein Kinase Signaling Pathway in Pre-Adolescent Children With Hypertrophic Cardiomyopathy
Summary-Hypertrophic cardiomyopathy (HCM) in children can be associated with malformation developmental syndromes, including Noonan syndrome (NS). NS and other related conditions are caused by mutations in genes encoding proteins of the RAS-mitogen activated protein kinase (MAPK) signaling pathway. Although diagnosis of these disorders is based on typical phenotypic features, the dysmorphic manifestations can be subtle and therefore overlooked. This study aimed to determine the prevalence of mutations in RAS-MAPK genes in 78 preadolescent children with apparently idiopathic HCM. Five probands (6.4%) carried novel sequence variants in 4 key genes of the RAS-MAPK pathway. Structural and molecular data suggest that these variants may have functional significance. Nine cardiac sarcomere protein genes were also screened; 2 individuals also had mutations in MYBPC. These findings suggest that genetic lesions promoting signaling dysregulation through RAS contribute to disease pathogenesis or progression in children with idiopathic and sarcomeric HCM. In particular, the results raise the possibility that some cases of HCM may represent incomplete phenotypic expression of RAS-MAPK disease. This has important implications for the evaluation and management of children with HCM, and further studies are needed to assess the possible interaction between sarcomere protein and RAS-MAPK genes.
Conclusions-This study reports novel and potentially pathogenic sequence variants in genes of the RAS-MAPK pathway, suggesting that genetic lesions promoting signaling dysregulation through RAS contribute to disease pathogenesis or progression in children with HCM.
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Outcomes After Stent Implantation for the Treatment of Congenital and Postoperative Pulmonary Vein Stenosis in Children
Summary-Intraluminal pulmonary vein stenosis is a progressive condition that is frequently lethal in children.Treatment approaches for relief of luminal stenosis are acutely successful, but with limited long-term benefit. Although intravascular stents are acutely successful in the relief of luminal stenosis, the rates of restenosis are high. Stents implanted at a larger diameter appear to remain patent longer with lower risk of reintervention.
Conclusions-Transcatheter stent implantation can acutely relieve pulmonary vein stenosis in children, but reintervention is common. Larger stent lumen size at implantation is associated with longer stent patency and a lower risk of reintervention.
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Circulating Matrix Metalloproteinases in Adolescents With Hypertrophic Cardiomyopathy and Ventricular Arrhythmia
Summary-Previous investigators have demonstrated the importance of fibrosis as a cardinal feature of hypertrophic cardiomyopathy (HCM) through postmortem pathology and contemporary imaging techniques. Serum biomarkers of collagen metabolism may also be a useful reflection of the fibrotic process within the myocardium, which may create a milieu for ventricular arrhythmias. Therefore, in consecutive adolescent patients with HCM, we compared circulating plasma concentrations of fibrosis biomarkers between those with remote history of serious ventricular arrhythmia versus those without ventricular arrhythmia history. We found that levels of matrix metalloproteinase 3 were significantly higher in patients with arrhythmias, and this difference persisted after adjustment for accepted sudden death risk factors in HCM. The association was attenuated after adjustment for age because the older patients in our cohort tend to be those followed after implantable cardioverter-defibrillator placement for serious arrhythmia. These data suggest that that arrhythmia propensity may be reflected in circulating biomarkers of extracellular matrix turnover. Future studies may determine whether these biomarkers may be able to predict serious arrhythmia in HCM patients and the precise mechanisms by which the processes reflected by these biomarkers may alter arrhythmia risk.
Conclusions-Circulating MMP3 may be a marker of ventricular arrhythmia in adolescent patients with HCM. Because of our role as pediatric providers, we cannot exclude age-related confounding.
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Prevalence of Sequence Variants in the RAS-Mitogen Activated Protein Kinase Signaling Pathway in Pre-Adolescent Children With Hypertrophic Cardiomyopathy
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Association of Physical Activity With Vascular Endothelial Function and Intima-Media Thickness
Summary-The development and progression of subclinical atherosclerosis in adolescence are associated with functional and structural changes of the arteries, including impairment of the arterial vasodilatory function and thickening of the arterial wall. Flow-mediated dilatation of the brachial artery, assessed noninvasively by ultrasound, is a widely used marker of systemic arterial endothelial function. Although the carotid artery has commonly been the target for ultrasonic assessment of early structural changes, the earliest morphological alterations emerge in the abdominal aorta. Intima-media thickness of the abdominal aorta may therefore be a better surrogate marker of atherosclerosis than carotid intima-media thickness especially at young age. Physical activity has a beneficial effect on vascular function and structure by enhancing endothelial function and decreasing the progression of carotid intima-media thickness. To date, data on the effect of physical activity on vascular function and structure in adolescents are scarce and longitudinal studies are lacking. Our study shows the favorable effect of leisure-time physical activity on flowmediated dilatation and intima-media thickness in nearly 500 adolescents studied repeatedly at 13, 15, and 17 years of age. Importantly, even a moderate increase in physical activity among those who were sedentary was related to a decreased progression of intima-media thickness. These results emphasize the potential of promoting physical activity, especially in inactive adolescents, to support cardiovascular health. Clinicians should encourage physical activity among adolescents, and enjoyable ways to increase physical activity should be paid attention to, especially for those who are sedentary.
Conclusions-Physical activity is favorably associated with endothelial function and IMT in adolescents. Importantly, a moderate increase in physical activity is related to decreased progression of IMT. A physically active lifestyle seems to prevent the development of subclinical atherosclerotic vascular changes in healthy adolescents. Summary-Fetal atrial flutter and supraventricular tachycardia may result in low cardiac output and death. Consequently, maternal antiarrhythmic treatment is offered in most affected pregnancies. This retrospective multicenter study is the first to compare the efficacy and safety of transplacental digoxin, flecainide, and sotalol, the most commonly used drugs to treat fetal tachyarrhythmia. In the absence of fetal hydrops, arrhythmia-related mortality was 0%, suggesting that transplacental antiarrhythmic therapy is safe and effective regardless of the drug chosen. In fetal hydrops, however, when rapid heart rate control becomes a matter of urgency to improve the chances of survival, the rate of arrhythmia-mediated death was 17%. We found that the fetal response to drug therapy was significantly associated with the type of tachycardia, fetal state, and choice of antiarrhythmic. Atrial flutter, fetal hydrops, and an incessant arrhythmia pattern were independently associated with slower cardioversion rates. Flecainide and digoxin were associated with increased likelihood of conversion of fetal supraventricular tachycardia to a normal rhythm and significantly greater slowing of ventricular rates of persistent atrial flutter/ supraventricular tachycardia than sotalol. The highest rate of prenatal atrial flutter termination was observed with sotalol, albeit this was achieved in only about half of the sotalol-treated patients. Flecainide or digoxin might therefore be considered first to treat significant fetal tachyarrhythmia, perhaps in combination with sotalol to treat poorly tolerated atrial flutter. Our results may also be useful in improving our understanding of the potentials and limitations of antiarrhythmic drug therapy and, in persistent arrhythmia, helping to define a treatment period after which an alternative management should be considered.
Conclusions-Flecainide and digoxin were superior to sotalol in converting subventricular tachycardia (SVT) to a normal rhythm and in slowing both AF and SVT to better-tolerated ventricular rates and therefore might be considered first to treat significant fetal tachyarrhythmia.
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Pediatric Pulmonary Hypertension in the Netherlands: Epidemiology and Characterization During the Period 1991 to 2005
Summary-In recent years, significant progress has been achieved in understanding the epidemiology and diagnosis of pulmonary hypertension (PH) in adults. In contrast, PH in children remains poorly understood because of a lack of epidemiological and clinical data. This study portrays epidemiological features, including incidence and prevalence, of pediatric PH and especially pulmonary arterial hypertension (PAH) based on nationwide data derived from 2 general medical registries (pediatric cardiology, national hospitalization) in the Netherlands during a 15-year period. This study demonstrates that pediatric PH is characterized by several age-specific diagnoses. Over 80% of these are transient forms of PAH not seen in adults. Progressive PAH in children includes idiopathic PAH (23%) but is mainly associated with congenital heart defects (PAH-CHD; 72%). Annual incidence for all PH diagnoses was 63.7 cases per million children. For iPAH and PAH-CHD, annual incidence and point prevalence averaged 0.7 and 4.4 (iPAH), and 2.2 and 15.6 (PAH-CHD) cases per million children. Incidence of pediatric iPAH was lower than reported in adults whereas incidence of pediatric PAH-CHD was higher. The group with pediatric PAH-CHD was more heterogeneous with highly variable clinical courses. Survival of Eisenmenger syndrome in children appeared to be worse than that reported in adults. Concomitant syndromes were frequent, especially in progressive PAH (39%). Notably, in the 15-year study period, only 71% of children with a diagnosis of PAH had confirmatory right heart catheterization as required by current guidelines, emphasizing the need for increasing specific clinical expertise. This can be reached by concentrating the care for pediatric PAH in specialized centers.
Conclusions-Pediatric PH is characterized by various age-specific diagnoses, the majority of which comprise transient forms of PAH.
Incidence of pediatric iPAH is lower whereas incidence of pediatric PAH-CHD is higher than reported in adults. Pediatric PAH-CHD represents a heterogeneous group with highly variable clinical courses. Summary-Advances in the management of congenital heart disease have improved the survival of individuals with even the most complex heart lesions, unmasking significant neurodevelopmental risk among survivors. Assessments conducted in early childhood have provided early data on the frequency and severity of neurodevelopmental morbidity. However, few studies have evaluated the neuropsychological and neuroimaging outcomes of adolescents with congenital heart disease. We evaluated 139 children 16 years of age with d-transposition of the great arteries who were enrolled as infants in the Boston Circulatory Arrest Study, a randomized trial comparing the outcomes associated with 2 vital organ support strategies: deep hypothermia with total circulatory arrest or with continuous flow-flow cardiopulmonary bypass. Adolescents in the 2 groups generally performed similarly. However, compared with the general population, adolescents in the combined treatment groups had lower, and more variable, scores on academic achievement, memory, attention, executive functions, visual-spatial skills, and social cognition. Almost two thirds had received remedial academic or behavioral services. Postoperative seizure, detected clinically or by continuous EEG recording, was the strongest predictor of poor outcomes. Structural MRI abnormalities were found in one third of the adolescents and were more frequently focal than diffuse, consisting of mineralization or iron deposits. Greater exposure to catheterization and longer time on cardiopulmonary bypass were independent risk factors for brain mineralization. Although most adolescents had satisfactory neuropsychological outcomes, a significant minority performed below the expected level.
Our results suggest that children with d-TGA should remain under surveillance into adolescence to permit identification of neurocognitive and behavioral difficulties.
Conclusions-Adolescents with d-transposition of the great arteries who have undergone the arterial switch operation are at increased neurodevelopmental risk. These data suggest that children with congenital heart disease may benefit from ongoing surveillance to identify emerging difficulties.
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Competing Risks for Death and Cardiac Transplantation in Children With Dilated Cardiomyopathy: Results From the Pediatric Cardiomyopathy Registry
Summary-Prior studies of outcomes for children with dilated cardiomyopathy (DCM) have used a composite end point of death and cardiac transplantation and may have missed identifying predictive factors differentially affecting outcomes, which affect the transplantation listing process. Using competing risk analysis, this study found that at the time of DCM diagnosis, the presence of congestive heart failure, echocardiographic evidence of more severe disease, and increased age at diagnosis predicted worse outcomes, with certain key differences between etiologic groups. For children with idiopathic disease, diagnosis after 6 years of age, congestive heart failure, decreased left ventricular (LV) fractional shortening, increased LV end-diastolic dimension, and decreased height-for-age predicted worse outcomes. Increased LV dilation was predictive of use of transplantation but not of mortality in idiopathic DCM, calling into question the importance of this factor in the decision to list for transplantation. Routine height measurement could highlight those with idiopathic DCM and lower height-for-age z scores who might require more urgent consideration for transplantation listing. For children with neuromuscular disease, decreased LV fractional shortening predicted death or transplantation, whereas increased LV end-diastolic dimension predicted transplantation but not death. For children with myocarditis, older age at diagnosis, congestive heart failure, and increased LV end-diastolic dimension predicted death or transplantation. These results suggest that the etiology of DCM modifies the importance of particular predictive factors. The ability to predict failed medical management may improve if the etiology of the cardiomyopathy can be established earlier. Additionally, analyses of registry data in this manner allow the postulation of predictive algorithms of clinical outcomes.
Conclusions-Risk factors for death and transplantation in children varied by DCM etiology. For idiopathic DCM, increased LV end-diastolic dimension was associated with increased transplantation risk but not mortality. Conversely, short stature was significantly related to death but not transplantation. These findings may present an opportunity to improve the transplantation selection algorithm. are limited in part because ECMO has never been approved by the Food and Drug Administration for this particular indication. In this study, data from the Extracorporeal Life Support Organization and Organ Procurement Transplant Network registries are combined to describe the efficacy and safety profile of ECMO for a bridge to heart transplantation and to propose objective performance goals that can be used as benchmarks to facilitate Food and Drug Administration approval of emerging miniaturized cardiac assist devices intended to replace ECMO. Among 733 children supported with ECMO as a bridge to heart transplantation since the mid-1990s, fewer than half survived to hospital discharge. Most deaths occurred while the children were on the wait list, but children successfully transplanted also had high posttransplantation mortality, accounting for up to one third of all in-hospital deaths. The risk of death was not uniform across all patient groups and varied by cardiac diagnosis, end-organ dysfunction, and duration of ECMO support. In the objective performance goal cohort, patients with cardiomyopathy had the highest survival to hospital discharge (63%), followed by patients with myocarditis (59%), 2-ventricle congenital heart disease (44%), and 1-ventricle congenital heart disease (33%). These findings suggest that, although ECMO may be effective for short-term circulatory support, it is not reliable for the long-term circulatory support necessary for children awaiting heart transplantation. Most important, these findings indicate that more effective modalities for long-term circulatory support are urgently needed for children.
Conclusions-Although ECMO is effective for short-term circulatory support, it is not reliable for the long-term circulatory support necessary for children awaiting heart transplantation. Fewer than half of patients bridged with ECMO survive to hospital discharge. More effective modalities for chronic circulatory support in children are urgently needed.
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Wrist Circumference Is a Clinical Marker of Insulin Resistance in Overweight and Obese Children and Adolescents
Summary-One of the major priorities of clinical practice is to identify young people at increased risk for obesity and insulin resistance, representing the metabolic basis for future cardiovascular disease. This study introduces a new clinical marker of insulin resistance in overweight/obese children and adolescents: the wrist circumference. This measurement has been historically included in the calculation of frame size, which is a parameter in evaluating the free fat mass to correct misclassification introduced by the use of body mass index. We produce the first evidence that wrist circumference is highly correlated with insulin resistance parameters (fasting insulin and homeostasis model assessment of insulin resistance index) in a population of overweight/obese children and adolescents. The association of wrist circumference with insulin resistance is explained only by the transversal wrist bone tissue-related areas and not by the wrist adipose tissue ones, reflecting the anabolic role of insulin on transversal bone growth. Wrist circumference is easily accessible and measurable by the doctor, minimizing the collaboration required of the patient, and its reproducibility is higher than that of waist circumference. Therefore, taking into account the high collinearity between the 2 parameters, wrist circumference could be considered in the classification of obesity for the prediction of insulin resistance and cardiovascular risk. In this cross-sectional study, we explored the association of DASH diet with blood lipid levels, lipoproteins, adipocytokines, and measures of adiposity and glycemic control in 2130 youth aged 10 to 22 years with physician-diagnosed diabetes mellitus. Dietary intake was assessed by food frequency questionnaire, categorized into the DASH food groups, and assigned an adherence score. In both type 1 and type 2 diabetes mellitus youth, the average DASH diet scores were low, suggesting very poor dietary intake quality in this population. Of the various cardiovascular disease risk factors evaluated, we found that among youth with type 1 diabetes mellitus, higher adherence to the DASH diet was significantly associated with lower levels of low-density lipoprotein/high-density lipoprotein ratio and A 1c . In youth with type 2 diabetes mellitus, higher adherence to the DASH diet was significantly associated with higher low-density lipoprotein particle density and lower body mass index Z score. In conclusion, the DASH dietary pattern may prove beneficial in the prevention and management of cardiovascular disease risk in this vulnerable population of youth with diabetes mellitus, among whom there is clearly much room for improvement in the quality of dietary intake.
Conclusions-The DASH dietary pattern may be beneficial in the prevention and management of cardiovascular disease risk in youth with diabetes mellitus. Summary-Children and young adults with functional single-ventricle physiology have decreased exercise capacity as a result of an inability to normally increase transpulmonary blood flow during exercise. A medication capable of decreasing pulmonary vascular resistance might allow improved transpulmonary flow and increased ventricular preload, resulting in improved cardiac output and performance with exercise. In this randomized, double-blind, placebo-controlled, crossover trial, the impact of sildenafil on exercise capacity was examined in a cohort of 28 subjects. The mean age of participants was 14.9 years, and the mean time from the Fontan operation was 11.3 years. In this cohort, sildenafil significantly improved ventilatory efficiency during peak and submaximal exercise. In 2 subgroups, those with single left or mixed ventricular morphology and those with a baseline serum brain natriuretic peptide level >100, an improvement in oxygen consumption at the anaerobic threshold was observed in subjects during the sildenafil phase. The findings of this study suggest that sildenafil may be a useful agent to improve exercise performance and activity tolerance in children and young adults with single-ventricle physiology after the Fontan operation. However, the long-term safety and efficacy of sildenafil in this patient population remain unknown.
Conclusions-In this cohort, sildenafil significantly improved ventilatory efficiency during peak and submaximal exercise. There was also a suggestion of improved oxygen consumption at the anaerobic threshold in 2 subgroups. These findings suggest that sildenafil may be an important agent for improving exercise performance in children and young adults with single-ventricle physiology after the Fontan operation.
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Determinants of Blood Pressure in Preschool Children: The Role of Parental Smoking
Summary-There is increasing evidence that environmental tobacco exposure has significant effects on cardiovascular health even at a young age. Abnormal arterial morphology and function have been demonstrated in teenagers exposed to second-hand smoking. The age at which cardiovascular effects of passive smoking first become detectable has not been established to date. This population-based study was designed to explore endogenous and exogenous determinants of blood pressure (BP) in preschool children. BP was measured in conjunction with a family health and lifestyle survey in a cohort of 4236 children aged 4 to 6 years. Multifactorial dependency of BP on body stature and familial, prenatal, and environmental influences was observed. Among these factors, exposure to parental smoking was associated with a small but consistent BP-raising effect, which remained significant when adjusted for numerous potentially collinear anthropometric, medical, and social factors affecting BP in the children and their parents, including prenatal conditions. Childhood BP was quantitatively correlated with the daily cigarette consumption of the mothers only, compatible with closer exposure to maternal smoking at home. The findings of this study add an important pediatric perspective to the issue of prevention and containment of active and passive smoking. They complete the picture of tobacco exposure interfering with cardiovascular maturation and health from gestation to adulthood. The benefit of successful primary prevention programs would most likely not be limited to adults but extend even to the youngest family members.
Conclusions-In healthy preschool children, parental smoking is an independent risk factor for higher blood pressure, adding to other familial and environmental risk factors. Implementing smoke-free environments at home and in public places may provide a long-term cardiovascular benefit even to young children. 35 
